Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04635995
What this trial is testing

Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Lyvgen Biopharma Holdings Limited 66
Testing effectiveness (Phase 2)Ended earlyNCT00780975
What this trial is testing

Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
PharmaMar 8
Large-scale testing (Phase 3)Ended earlyNCT05269355
What this trial is testing

Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Who this might be right for
Leiomyosarcoma
PTC Therapeutics 359
Early research (Phase 1)Study completedNCT04659629
What this trial is testing

NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer

Who this might be right for
Solid TumorAdvanced Solid Tumor
Neurogene Inc. 59
Testing effectiveness (Phase 2)Study completedNCT01253837
What this trial is testing

L19TNFα in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsColorectal Cancer
Philogen S.p.A. 34
Testing effectiveness (Phase 2)Study completedNCT02109328
What this trial is testing

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Who this might be right for
Bladder CancerTransitional Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT02541370
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Who this might be right for
Liver CancerPancreatic CancerBrain Tumor+4 more
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01681368
What this trial is testing

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)UnknownNCT01799083
What this trial is testing

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas

Who this might be right for
Solid TumorsB Cell Lymphoma
Han weidong 100
Testing effectiveness (Phase 2)Study completedNCT00064012
What this trial is testing

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Wisconsin, Madison 4
Early research (Phase 1)Active Not RecruitingNCT04419532
What this trial is testing

A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Solid Tumor
Daiichi Sankyo 40
Early research (Phase 1)Looking for participantsNCT06484816
What this trial is testing

TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorHematologic Malignancy
Shenzhen TargetRx Co., Ltd. 90
Early research (Phase 1)Active Not RecruitingNCT04279847
What this trial is testing

Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Who this might be right for
MyelofibrosisMyelodysplastic SyndromeMyelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome+4 more
Incyte Corporation 140
Testing effectiveness (Phase 2)Study completedNCT02193958
What this trial is testing

Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
AMLCMMLMDS
Fujifilm Pharmaceuticals U.S.A., Inc. 55
Early research (Phase 1)Ended earlyNCT03051035
What this trial is testing

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Who this might be right for
Advanced Malignant Neoplasm
Kura Oncology, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT00101413
What this trial is testing

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Who this might be right for
CancerCarcinoma, Non-Small Cell Lung
Bayer 52
Testing effectiveness (Phase 2)Ended earlyNCT04775680
What this trial is testing

Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma

Who this might be right for
Solid TumorNon Hodgkin Lymphoma
Adagene (Suzhou) Limited 25
Testing effectiveness (Phase 2)Looking for participantsNCT04390737
What this trial is testing

Evaluate the Safety and Clinical Activity of HH2853

Who this might be right for
FL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more
Haihe Biopharma Co., Ltd. 254
Next Page